ALPN — ALPINE IMMUNE SCIENCES INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-07 · 来源: SEC EDGAR Form 13F-HR
HoldingsHub 追踪了 ALPN(ALPINE IMMUNE SCIENCES INC)近五年的季度 13F 申报数据。历史上有 196 家基金申报过持仓,其最近一期申报市值合计 $2.53B。最新季度无机构披露持仓,通常意味着该股已退出追踪基金的组合,而非不可投资。
ALPINE IMMUNE SCIENCES INC(ALPN)的主要机构持有人包括 Decheng Capital LLC、Avoro Capital Advisors LLC、Frazier Life Sciences Management, L.P.,按 13F 申报市值在本页 196 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q1 2024 | 179 | 63.71M | $2.40B | +0.4% |
| Q4 2023 | 131 | 57.40M | $1.06B | +19.3% |
| Q3 2023 | 88 | 37.87M | $417.61M | +32.5% |
| Q2 2023 | 22 | 4.08M | $41.73M | +38.9% |
| Q1 2023 | 17 | 2.75M | $21.10M | +4.2% |
| Q4 2022 | 17 | 2.66M | $19.41M | +29.4% |
| Q3 2022 | 18 | 2.10M | $15.15M | +27.3% |
| Q2 2022 | 19 | 1.65M | $14.03M | -0.3% |
表内 8 个季度中,机构持股合计增加 3763%(Q2 2022 → Q1 2024);单季变动最大的是 Q2 2023(+38.9%)。
前 25 大机构持仓人(Q1 2024) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 8.32M | $329.72M | 44.22% | 增持 | |
| 5.78M | $228.92M | 2.67% | 新进 | |
| 3.13M | $124.11M | 5.24% | 持有 | |
| 3.08M | $122.10M | 0.01% | 增持 | |
| 2.85M | $112.81M | 0.01% | 增持 | |
| 2.71M | $107.51M | 0.00% | 增持 | |
| 2.70M | $107.03M | 4.70% | 增持 | |
| 2.68M | $106.25M | 1.99% | 增持 | |
| 2.25M | $89.32M | 23.00% | 减持 | |
| 2.12M | $84.08M | 2.96% | 减持 | |
| 1.98M | $78.57M | 10.46% | 新进 | |
| 1.38M | $54.51M | 3.65% | 减持 | |
| 1.24M | $49.21M | 7.35% | 持有 | |
| 1.17M | $46.57M | 1.67% | 新进 | |
| 1.13M | $44.73M | 6.97% | 减持 | |
| 1.09M | $43.33M | 0.02% | 减持 | |
| 910.60K | $36.10M | 0.00% | 增持 | |
| 789.64K | $31.30M | 0.00% | 增持 | |
| 668.77K | $26.51M | 0.06% | 增持 | |
| 520.50K | $20.79M | 1.63% | 减持 | |
| 519.97K | $20.61M | 0.05% | 增持 | |
| 501.24K | $19.87M | 1.52% | 新进 | |
| 450.83K | $17.84M | 0.01% | 减持 | |
| 428.56K | $16.99M | 0.05% | 增持 | |
| 428.56K | $16.99M | 0.02% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q4 2023 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.08M | $135.01M | 37.72% | 新进 | |
| 4.91M | $93.58M | 1.46% | 增持 | |
| 3.81M | $72.69M | 28.58% | 增持 | |
| 3.70M | $70.59M | 12.03% | 增持 | |
| 3.18M | $60.55M | 2.92% | 增持 | |
| 3.13M | $59.68M | 3.19% | 增持 | |
| 2.55M | $48.60M | 2.32% | 增持 | |
| 2.54M | $48.32M | 0.96% | 减持 | |
| 2.23M | $42.59M | 0.00% | 增持 | |
| 1.69M | $32.16M | 0.00% | 增持 | |
| 1.61M | $30.69M | 2.68% | 增持 | |
| 1.39M | $26.49M | 0.00% | 增持 | |
| 1.24M | $23.66M | 3.79% | 增持 | |
| 1.22M | $23.26M | 0.01% | 新进 | |
| 1.00M | $19.06M | 0.21% | 减持 | |
| 819.27K | $15.62M | 1.28% | 减持 | |
| 764.35K | $14.57M | 0.00% | 增持 | |
| 718.74K | $13.70M | 0.00% | 增持 | |
| 714.59K | $13.62M | 0.03% | 新进 | |
| 583.24K | $11.12M | 0.01% | 新进 | |
| 487.25K | $9.29M | 1.78% | 新进 | |
| 470.00K | $8.96M | 0.06% | 新进 | |
| 378.41K | $7.21M | 0.02% | 增持 | |
| 365.94K | $6.97M | 0.07% | 增持 | |
| 357.27K | $6.81M | 4.06% | 新进 |
Q3 2023 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.69M | $53.71M | 1.06% | 新进 | |
| 4.08M | $46.73M | 1.03% | 新进 | |
| 3.08M | $35.25M | 6.81% | 新进 | |
| 2.99M | $34.19M | 2.28% | 新进 | |
| 2.42M | $27.73M | 1.93% | 新进 | |
| 2.40M | $27.53M | 18.21% | 新进 | |
| 1.90M | $21.75M | 1.27% | 新进 | |
| 1.47M | $16.89M | 0.00% | 增持 | |
| 1.40M | $15.99M | 0.00% | 新进 | |
| 1.32M | $15.17M | 1.77% | 新进 | |
| 1.19M | $13.66M | 0.62% | 新进 | |
| 1.04M | $11.89M | 0.14% | 新进 | |
| 914.91K | $10.48M | 1.15% | 新进 | |
| 750.00K | $8.59M | 1.87% | 新进 | |
| 657.28K | $7.53M | 0.30% | 新进 | |
| 628.92K | $7.20M | 0.00% | 增持 | |
| 605.54K | $6.93M | 0.00% | 新进 | |
| 464.81K | $5.32M | 0.00% | 减持 | |
| 314.03K | $3.60M | 1.15% | 新进 | |
| 288.19K | $3.30M | 0.01% | 减持 | |
| 270.42K | $3.10M | 0.00% | 增持 | |
| 246.07K | $2.82M | 0.01% | 新进 | |
| 234.26K | $2.68M | 0.00% | 新进 | |
| 234.26K | $2.68M | 0.00% | 增持 | |
| 217.14K | $2.49M | 0.00% | 新进 |
Q2 2023 — 22 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.40M | $14.43M | 0.00% | 增持 | |
| 675.59K | $6.95M | 0.00% | 增持 | |
| 617.97K | $6.35M | 0.00% | 增持 | |
| 319.29K | $3.28M | 0.01% | 减持 | |
| 257.52K | $2.65M | 0.00% | 增持 | |
| 127.33K | $1.31M | 0.00% | 增持 | |
| 116.17K | $1.19M | 0.00% | 新进 | |
| 91.51K | $940.69K | 0.00% | 增持 | |
| 86.28K | $886.96K | 0.00% | 增持 | |
| 58.03K | $596.53K | 0.00% | 新进 | |
| 56.02K | $575.92K | 0.00% | 新进 | |
| 55.77K | $573.37K | 0.00% | 增持 | |
| 50.20K | $516.10K | 0.00% | 增持 | |
| 45.85K | $471.34K | 0.00% | 增持 | |
| 26.35K | $270.87K | 0.00% | 减持 | |
| 17.91K | $184.16K | 0.00% | 减持 | |
| 13.84K | $142.32K | 0.00% | 新进 | |
| 13.48K | $138.60K | 0.00% | 新进 | |
| 12.68K | $130.36K | 0.00% | 增持 | |
| 10.28K | $105.64K | 0.00% | 增持 | |
| 3.49K | $35.90K | 0.00% | 增持 | |
| 21.74K | $224 | 0.00% | 增持 |
Q1 2023 — 17 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.37M | $10.57M | 0.00% | 增持 | |
| 556.21K | $4.29M | 0.00% | 增持 | |
| 330.29K | $2.55M | 0.00% | 减持 | |
| 193.99K | $1.50M | 0.00% | 增持 | |
| 71.81K | $554.34K | 0.00% | 减持 | |
| 67.27K | $519.29K | 0.00% | 增持 | |
| 30.86K | $238.22K | 0.00% | 增持 | |
| 30.03K | $232.00K | 0.00% | 增持 | |
| 27.91K | $215.50K | 0.00% | 增持 | |
| 23.50K | $181.42K | 0.00% | 减持 | |
| 14.75K | $113.88K | 0.00% | 增持 | |
| 7.99K | $61.71K | 0.00% | 增持 | |
| 4.39K | $33.91K | 0.00% | 新进 | |
| 2.47K | $19.09K | 0.00% | 持有 | |
| 1.26K | $9.70K | 0.00% | 增持 | |
| 523 | $4.04K | 0.00% | 减持 | |
| 19.62K | $152 | 0.00% | 增持 |
Q4 2022 — 17 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.36M | $10.00M | 0.00% | 增持 | |
| 485.75K | $3.57M | 0.00% | 增持 | |
| 332.89K | $2.45M | 0.00% | 减持 | |
| 191.57K | $1.41M | 0.00% | 增持 | |
| 83.59K | $614.39K | 0.00% | 增持 | |
| 64.50K | $474.05K | 0.00% | 增持 | |
| 30.49K | $224.09K | 0.00% | 增持 | |
| 23.67K | $173.95K | 0.00% | 增持 | |
| 22.40K | $164.67K | 0.00% | 新进 | |
| 17.56K | $129.07K | 0.00% | 增持 | |
| 14.23K | $105.00K | 0.00% | 增持 | |
| 8.15K | $59.94K | 0.00% | 增持 | |
| 2.47K | $18.15K | 0.00% | 增持 | |
| 2.28K | $16.73K | 0.00% | 新进 | |
| 680 | $5.00K | 0.00% | 增持 | |
| 594 | $4.37K | 0.00% | 减持 | |
| 19.40K | $143 | 0.00% | 增持 |
新建仓(最新)
本季度没有基金新建该仓位。
完全清仓(较上季)
本季度没有被追踪基金完全清仓。
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Decheng Capital LLC | 8.32M | 7.08M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Avoro Capital Advisors LLC | 5.78M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Frazier Life Sciences Management, L.P. | 3.13M | 3.13M | 2.99M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.08M | 1.69M | 1.40M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.85M | 1.39M | 605.54K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | 2.71M | 2.23M | 1.47M | 1.40M | 1.37M | 1.36M | 1.12M | 629.77K | 707.60K | 697.75K | 580.48K | 575.22K | 575.34K | — | — | — | — | — | — | — |
| Cormorant Asset Management, LP | 2.70M | 2.55M | 1.90M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ORBIMED ADVISORS LLC | 2.68M | 2.54M | 4.08M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Lynx1 Capital Management LP | 2.25M | 3.81M | 2.40M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Paradigm Biocapital Advisors LP | 2.12M | 3.18M | 2.42M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Darwin Global Management, Ltd. | 1.98M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Commodore Capital LP | 1.38M | 1.61M | 1.32M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Octagon Capital Advisors LP | 1.24M | 1.24M | 750.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Avidity Partners Management LP | 1.17M | — | 657.28K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GREAT POINT PARTNERS LLC | 1.13M | 3.70M | 3.08M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Franklin Resources | 1.09M | 1.22M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 910.60K | 764.35K | 628.92K | 617.97K | 556.21K | 485.75K | 251.50K | 247.99K | 215.16K | 196.67K | 194.02K | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 789.64K | 718.74K | 53.47K | 50.20K | 27.91K | 17.56K | 11.56K | 13.20K | 9.28K | 9.14K | 2.73K | — | — | — | — | — | — | — | — | — |
| TWO SIGMA ADVISERS, LP | 668.77K | 264.07K | 246.07K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vivo Capital, LLC | 520.50K | 819.27K | 914.91K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
常见问题
Which funds hold ALPN?
196 funds have reported positions in ALPN across five years of 13F filings; the sum of their latest reported stakes is $2.53B.
Who are the top institutional holders of ALPN?
The largest 13F holders are Decheng Capital LLC, Avoro Capital Advisors LLC, Frazier Life Sciences Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ALPINE IMMUNE SCIENCES INC?
The major shareholders of ALPINE IMMUNE SCIENCES INC (ALPN) by reported 13F value are Decheng Capital LLC, Avoro Capital Advisors LLC, Frazier Life Sciences Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, among 196 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.